Association of low serum ferritin levels with augmentation in patients with restless legs syndrome: A systematic review and meta-analysis

• Published in: Sleep medicine 2023-12, Vol.112, p.173-180
• Main Authors: Li, Ying-Sheng, Yeh, Wei-Chih, Hsu, Chung-Yao
• Format: Article
• Language: English
• Subjects: Augmentation; Dopamine Agents - therapeutic use; Ferritin; Ferritins; Humans; Iron - therapeutic use; Iron deficiency; Levodopa - therapeutic use; meta-Analysis; Observational Studies as Topic; Restless legs syndrome; Restless Legs Syndrome - etiology
• ISSN: 1389-9457; 1878-5506
• DOI: 10.1016/j.sleep.2023.10.022

Augmentation of restless legs syndrome (RLS) is an iatrogenic side effect induced by dopaminergic agents, and it is a major cause of therapeutic failure. Iron deficiency is a risk factor for RLS, but its effects on the development of RLS augmentation are unclear. This meta-analysis aimed to elucidate the association between serum ferritin and RLS augmentation. We searched the PubMed, Cochrane Library, Embase, ClinicalKey, ScienceDirect, and ProQuest databases for studies comparing the serum ferritin levels of patients with augmented RLS and nonaugmented RLS. A meta-analysis based on a random-effects model was conducted. Levodopa equivalent dose (LED), International Restless Legs Study Group Severity Rating Scale (IRLS), and serum hemoglobin levels were also analyzed. Six observational studies fulfilled the eligibility criteria of this meta-analysis. A total of 220 RLS patients with augmentation and 687 RLS patients without augmentation were included. The results revealed that augmented RLS was significantly associated with low serum ferritin levels (p = 0.002), high LEDs (p = 0.026), and nonsignificantly associated with high IRLS scores (p = 0.227). A low serum ferritin level is associated with RLS augmentation. For patients with RLS who are iron deficient, iron supplements can not only relieve their fundamental RLS symptoms but also lower the risk of RLS augmentation. Moreover, non-dopminergic agents should be considered as the first-line treatment for patients with persistent low serum ferritin levels or those with moderate to severe RLS to prevent augmentation. •The relationship between augmentation of restless legs syndrome and low iron storage was controversial in previous studies.•A low serum ferritin level was associated with augmentation of restless legs syndrome according to the meta–analysis.•Higher RLS severity and higher doses of dopaminergic agents were also related to augmentation.